A Randomized Clinical Trial to Compare Fleroxacin-Rifampicin with Flucloxacillin or Vancomycin for the Treatment of Staphylococcal Infection | Zendy

Jacques Schrenzel | Zendy; Stephan Harbarth | Zendy; G Schockmel | Zendy; Daniel Genné | Zendy; Thomas Bregenzer | Zendy; U. Flueckiger | Zendy; Christiane Pétignat | Zendy; Frédéric Jacobs | Zendy; P Francioli | Zendy; W. Zimmerli | Zendy; Daniel P. Lew | Zendy

Open Access

A Randomized Clinical Trial to Compare Fleroxacin-Rifampicin with Flucloxacillin or Vancomycin for the Treatment of Staphylococcal Infection

Author(s) -

Jacques Schrenzel,

Stephan Harbarth,

G Schockmel,

Daniel Genné,

Thomas Bregenzer,

U. Flueckiger,

Christiane Pétignat,

Frédéric Jacobs,

P Francioli,

W. Zimmerli,

Daniel P. Lew

Publication year - 2004

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/424506

Subject(s) - medicine , flucloxacillin , rifampicin , fleroxacin , vancomycin , bacteremia , surgery , population , adverse effect , randomized controlled trial , antibiotics , staphylococcus aureus , ofloxacin , ciprofloxacin , microbiology and biotechnology , tuberculosis , pathology , biology , bacteria , genetics , environmental health

Oral combination therapy with fluoroquinolones plus rifampicin is a promising alternative to standard parenteral therapy for staphylococcal infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research